Tsiporah B. Shore   Professor of Clinical Medicine

  • (212) 746-2119 (Clinical)

Associate Professor of Clinical Medicine

Dr. Shore does research in stem cell/ bone marrow transplantation as well as hematological malignancies and melanoma. She is involved in multiple clinical trials including those of the CALGB National Cancer Clinical Trials organization. Dr. Shore has developed a novel nonmyeloablative regimen for stem cell transplantaion and has conducted Phase I/ II research on this protocol. The data from this study was chosen to be presented at the American Society of Clinical Oncology in 2004. Dr. Shore is also a member of the New York Cancer Consortium as well as a primary investigator for various pharmaceutical sponsored clinical trials.


Sort by

Selected publications


Sort by

Select federal grants awarded

  • Early Therapeutics Development with Phase II Emphasis  awarded by National Cancer Institute Key Personnel 2006 - 2011
  • Renal Allograft Tolerance Through Mixed Chimerism Key Personnel 2009 - 2011
  • Phase III Rituxan/BEAM vs. Bexxar/BEAM with Autologous Hematopoietic Stem Cell Transplantation (ASCT) for Persistent or Relapsed Chemotherapy...  awarded by National Heart, Lung, & Blood Institute Principal Investigator Subaward 2008 - 2009



full name

  • Dr. Tsiporah B Shore

primary email

  • tbs2001@med.cornell.edu


Primary Affiliation

  • Weill Cornell Medical College, Cornell University